ABSTRACT
We detail the history and evaluation of a 68-year-old man who had head-to-toe PET/CT scanning that showed a focal area of increased FDG uptake in the left medial foot. This was thought to be recurrence of his melanoma. The patient was asymptomatic. He had a history of malignant melanoma of the right ear, which was removed in 2001. On biopsy, the foot lesion was diagnosed as plantar fibromatosis. Plantar fibromatosis is a benign fibroblastic condition, which can be indistinguishable from malignancy in head-to-toe PET/CT scans. Awareness of their potential appearance on PET and PET/CT will aid in the appropriate staging of oncology patients.
Subject(s)
Fibroma/diagnosis , Fluorodeoxyglucose F18 , Foot Diseases/diagnosis , Positron-Emission Tomography/methods , Soft Tissue Neoplasms/diagnosis , Aged , Fibroma/metabolism , Fluorodeoxyglucose F18/pharmacokinetics , Foot Diseases/metabolism , Humans , Male , Radiopharmaceuticals/pharmacokinetics , Soft Tissue Neoplasms/metabolism , Tomography, X-Ray ComputedABSTRACT
PURPOSE: The purpose of the study is to describe the rare tumor on 2-deoxy-2[F-18]fluoro-D-glucose (FDG) positron emission tomography (PET). PROCEDURE: A 33-year-old male was diagnosed with high uptake lesion on FDG-PET scanning, which was found to be hibernoma on excision. RESULTS: Hibernoma, originally confused with liposarcoma based on its PET and computed tomography presentation, was excised and correctly identified by pathology. CONCLUSION: Although found to be benign, radiological and FDG-PET scanning results were indistinguishable from malignancy, and biopsy is required to exclude neoplasm.